CXCL12 and diabetes mellitus: Additionally, our findings revealed that having higher plasma SDF-1 levels were associated with an increased risk of recurrent stroke and cardiovascular events at two years in patients with diabetes mellitus, although this association was not as strong as observed for outcomes at one year.